Expert Commentary
View AllPublications
Chronic opioid therapy and preventive services in rural primary care: an Oregon rural practice-based research network study.
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
The role of core strengthening for chronic low back pain.
Buckley DI, Calvert JF, Lapidus JA, et al.
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
Ann Fam Med. 2010;8(3):237-44.
PURPOSE:...
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain
Beck JG, Clapp JD.
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
Psychol Trauma. 2011 Jun;3(2):101-108.
Many traumatic events leave...
The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic
Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.
Pain Res Manag. 2011...
Pain Res Manag. 2011...
Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids
Barth KS, Becker WC, Wiedemer NL, Mavandadi S, Oslin DW, Meghani SH, Gallagher RM.
J Addict...
J Addict...
The role of core strengthening for chronic low back pain.
Akuthota V, Standaert CJ, Chimes GP.
PM R. 2011 Jul;3(7):664-70.
PM R. 2011 Jul;3(7):664-70.






Relative Pain Levels in Patients at High Risk for Substance Misuse
Robert N. Jamison, PhD
Pain Management Center
Departments of Anesthesia and Psychiatry
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts
The Screener and Opioid Assessment for Patients with Pain (SOAPP) is a brief self-report questionnaire that assesses patients for risk factors associated with potential opioid misuse. Jamison et al. sought to identify differences among patients with chronic pain who were stratified as either low or high risk based on their SOAPP scores. At baseline, high-risk patients reported significantly higher levels of pain intensity, activity interference, pain catastrophizing, disability, and depressed mood. The only difference observed over time, however, was higher self-reported pain levels in the high-risk group. These results suggest that the SOAPP may allow clinicians not only to stratify patients based on the risk for opioid-related aberrant behaviors, but also to identify patients who may experience more pain.
References